DB
David Bedwell
Member of Scientific Advisory BoardDr. David Bedwell, Ph.D., has been Member of Scientific Advisory Board at Eloxx Pharmaceuticals, Inc. since May 10, 2018. Dr. Bedwell is a Professor and Chairman of James C. and Elizabeth T. Lee Endowed Chair of Biochemistry, Department of Biochemistry & Molecular Genetics, University of Alabama at Birmingham School of Medicine. Dr. Bedwell also currently serves as Associate Director of the Cystic Fibrosis Research Center and Co-Director of the UAB Structural Biology Program. He was elected Fellow of the American Academy of Microbiology in 2011. Dr. Bedwell’s lab studies the mechanistic details of translation termination and Nonsense-Mediated mRNA Decay (NMD).
Positions
- Company NameEloxx Pharmaceuticals, Inc.Stock CodeELOXPositionMember of Scientific Advisory BoardColleagues
- SASumit AggarwalPresident, CEO & Director
- AEAlan Edmund WaltsIndependent Chairman
- DEDaniel E. GeffkenInterim Chief Financial Officer
- JWJohn WoolfordVP & Head of Corporate Development
- RCRoger ClarkVP & Head of Discovery Sciences
- TSTeji SinghVP & Head of Clinical Development
- SDSteven D. RubinIndependent Director
- RGRachel GreenMember of Scientific Advisory Board
